BackEli Lilly and Company Overview

Eli Lilly and Company Intangible Assets

Latest intangible assets for LLY.DE: $18B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$18.11B
↑ 206.52% YoYΔ $12.20B vs prior year quarter

Peer trimmed avg / median

Loading

Eli Lilly and Company Intangible Assets History

Loading

Eli Lilly and Company vs. peers: Intangible Assets Comparison

Loading

Eli Lilly and Company Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eli Lilly and Company (LLY.DE) FAQ

As of the most recent data (June 2026), LLY.DE shows a intangible assets of $18B. That compares with $5.9B in the prior-year period — up 206.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LLY.DE's intangible assets is now $18B (was $5.9B) — a 206.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Eli Lilly and Company is outperforming or lagging.

Tracking LLY.DE's intangible assets over time shows whether Eli Lilly and Company is scaling, shrinking, or reshaping that part of the business. The current reading is $18B That compares with $5.9B in the prior-year period — up 206.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Eli Lilly and Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $18B) with ownership activity and broader fundamentals.

Eli Lilly and Company's intangible assets is $18B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.